VIVOJECT Trademark

Trademark Overview


On Friday, October 25, 2024, a trademark application was filed for VIVOJECT with the United States Patent and Trademark Office. The USPTO has given the VIVOJECT trademark a serial number of 98820324. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, May 2, 2025. This trademark is owned by Revvity Health Sciences, Inc.. The VIVOJECT trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Medical Instrument Products categories with the following description:

Medical laboratory research instruments for pharmaceutical research; Medical laboratory research instruments for use with in vivo imaging devices; Ultrasound inspection devices for non-medical, non-destructive testing; Medical laboratory research instruments for ultrasound system; Medical imaging apparatus for small animals, in a research laboratory environment

Drug delivery devices sold empty, namely, injection instruments; Medical devices and apparatus, namely, medical guidewires and parts and fittings therefor; Medical devices and apparatus, namely, ultrasound imaging apparatus, scanners and needle guides, and parts and fittings therefor; Injection instruments with needles
vivoject

General Information


Serial Number98820324
Word MarkVIVOJECT
Filing DateFriday, October 25, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, May 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical laboratory research instruments for pharmaceutical research; Medical laboratory research instruments for use with in vivo imaging devices; Ultrasound inspection devices for non-medical, non-destructive testing; Medical laboratory research instruments for ultrasound system; Medical imaging apparatus for small animals, in a research laboratory environment
Goods and ServicesDrug delivery devices sold empty, namely, injection instruments; Medical devices and apparatus, namely, medical guidewires and parts and fittings therefor; Medical devices and apparatus, namely, ultrasound imaging apparatus, scanners and needle guides, and parts and fittings therefor; Injection instruments with needles

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, October 25, 2024
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, October 25, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRevvity Health Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events


Event DateEvent Description
Friday, October 25, 2024NEW APPLICATION ENTERED
Friday, October 25, 2024APPLICATION FILING RECEIPT MAILED
Thursday, April 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 2, 2025NON-FINAL ACTION E-MAILED
Friday, April 25, 2025ASSIGNED TO EXAMINER
Friday, May 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 2, 2025NON-FINAL ACTION WRITTEN